RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. CDTI Innovación's INNVIERTE program
C

CDTI Innovación's INNVIERTE program portfolio

CDTI Innovación's INNVIERTE program has 2 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is Ona Therapeutics's $86.6M Series B+ round in June 2026, alongside Mérieux Equity Partners, Columbus Venture Partners, Ysios Capital and 6 others. By category, its portfolio leans toward Health and bio (1) and Data and analytics (1).

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 1.
Capital in their rounds: $86.6M.
Latest deal: Ona Therapeutics · Jun 4, 2026.

What CDTI Innovación's INNVIERTE program invests in

How CDTI Innovación's INNVIERTE program invests

StageDealsCapital in rounds
Series B+ 1 100%$86.6M

Share is of the 1 round on Recent Funding that name CDTI Innovación's INNVIERTE program. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

CDTI Innovación's INNVIERTE program portfolio companies

CompanyRound with CDTI Innovación's INNVIERTE programTotal raisedLatest raise
OOna Therapeutics
Health and bio
Series B+ · $86.6M$207.12MOct 5, 2026
Series B+
XXoople
Data and analytics
backer$130MApr 6, 2026
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists CDTI Innovación's INNVIERTE program, which is a subset of its real portfolio. API: /api/v1/investors/cdti-innovacio-n-s-innvierte-program (get a free API key). More: the most active VC firms and new venture capital funds.